Healthcare & Medical Devices Global On demand · 24-48h

Global Liver Elastography Machine Market Strategic Research Report

Global Liver Elastography Machine Market Strategic Research …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Liver Elastography Machine Market
$2892025
9.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Trolley-mounted, Portable

By Application: Hospitals & Clinics, Physical Examination Centers

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Echosens (Furui Medical), GE HealthCare, Royal Philips, Siemens Healthineers AG, Canon Medical, FUJIFILM Healthcare, Hologic, Wuxi Haisi Kaier Medical Technology, Shenzhen Energy Technology Group, Mindray, Eieling Technology Limited

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 110 pages
Market size 2025
$289
Million USD
Forecast CAGR
9.5%
2025-2032
Forecast 2032
$545.5
Projected
Gebieden
5
Asia Pacific · Latin America · MEA · Europe · North America

Overzicht

Scope of the Report

The global Liver Elastography Machine market size is predicted to grow from US$ 289 million in 2025 to US$ 536 million in 2032; it is expected to grow at a CAGR of 9.5% from 2026 to 2032.

In 2025, global Liver Elastography Machine production reached approximately 3,837 units, with an average global market price of around US$77,000 per unit. A liver elastography machine is a specialized medical device used to measure the stiffness of your liver. It is a safe, painless, and non-invasive alternative to a traditional liver biopsy. It helps doctors detect and monitor liver scarring (fibrosis) caused by conditions like fatty liver disease or hepatitis.

The global liver elastography machine market features a competitive landscape coexisting with specialized manufacturers and large medical imaging enterprises. Specialized manufacturers focusing on liver detection hold a leading position in the dedicated equipment market through first-mover technological advantages and extensive clinical validation data, with their products recommended in clinical guidelines by global authoritative institutions including the World Health Organization, the European Association for the Study of the Liver, and the American Association for the Study of Liver Diseases. Large medical imaging enterprises participate in market competition by integrating elastography modules into general ultrasound systems, leveraging their technological accumulation and global channel advantages in ultrasound and magnetic resonance fields. Liver fibrosis, as the core intermediate stage in the progression of all types of chronic liver diseases, constitutes the fundamental basis of market demand with its widespread disease burden. Patients with chronic liver diseases of various etiologies face the risk of liver fibrosis progression, and the early reversibility of liver fibrosis determines that early detection and intervention are decisive for improving patient prognosis and reducing the incidence of end-stage liver diseases. The invasiveness, sampling error and potential complications of traditional liver biopsy limit its application in large-scale screening and long-term dynamic monitoring, and this clinical pain point directly creates an urgent demand for non-invasive liver elastography technology. In clinical practice, patients with liver fibrosis require not only initial diagnostic grading but also regular monitoring of disease progression and treatment response, and this full-course management demand further expands the usage scenarios and frequency of liver elastography machines. The increasing attention paid by national public health systems to chronic liver disease prevention and control, the inclusion of liver fibrosis screening in key public health programs, the promotion of non-invasive testing equipment popularization in primary medical institutions, and the expansion of coverage for relevant testing items by national medical insurance systems, jointly release sustained market demand. Industry technological development is based on transient elastography, while evolving toward simultaneous multi-parameter detection, artificial intelligence-assisted analysis, and device portability. New-generation products integrate assessment capabilities for liver stiffness, steatosis, and spleen stiffness, improving diagnostic accuracy and the value of full-course disease management. Chinese domestic enterprises have made important progress in core technology research and product registration. Their product performance has gradually approached the international advanced level, obtained regulatory certifications in many countries and regions, achieved rapid substitution in the domestic market, and started to expand overseas markets. The industry still faces some challenges. The diagnostic consistency of different technical routes needs to be further unified, and the physician operation training and quality control systems in primary medical institutions still need to be improved.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Liver Elastography Machine market?

What factors are driving Liver Elastography Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Liver Elastography Machine market opportunities vary by end market size?

How does Liver Elastography Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Liver Elastography Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Trolley-mounted
  • Portable

Segment by Technology

  • Transient Elastography
  • Shear Wave Elastography

Segment by Parameter

  • Single-parameter
  • Dual-/Multi-parameter

Segment by Application

  • Hospitals & Clinics
  • Physical Examination Centers

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Liver Elastography Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospitals & Clinics, Physical Examination Centers evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Liver Elastography Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 9.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$289
2025
Forecast
$545.5
2032
CAGR
9.5%
2025–2032
Gebieden
5
global
Key companies
Echosens (Furui Medical)GE HealthCareRoyal PhilipsSiemens Healthineers AGCanon MedicalFUJIFILM HealthcareHologicWuxi Haisi Kaier Medical Technology
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Trolley-mountedPortable
By Application
Hospitals & ClinicsPhysical Examination Centers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Trolley-mounted
  • 3.1.3 Portable
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospitals & Clinics
  • 4.1.3 Physical Examination Centers
  • 4.1.4 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Echosens (Furui Medical)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 GE HealthCare
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Royal Philips
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Siemens Healthineers AG
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Canon Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 FUJIFILM Healthcare
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Hologic
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Wuxi Haisi Kaier Medical Technology
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Shenzhen Energy Technology Group
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Mindray
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Eieling Technology Limited
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

How big is the global Liver Elastography Machine market?
The global Liver Elastography Machine market is estimated at US$ 289 million in 2025 (base year) and is projected to reach US$ 536 million by 2032.
How fast is the Liver Elastography Machine market expected to grow?
The market is expected to grow at a CAGR of 9.5% from 2026 to 2032, expanding from US$ 289 million in 2025 to US$ 536 million in 2032, roughly 1.9 times its base-year value.
What does the Liver Elastography Machine market cover?
In 2025, global Liver Elastography Machine production reached approximately 3,837 units, with an average global market price of around US$77,000 per unit. A liver elastography machine is a specialized medical device used to measure the stiffness of your liver. It is a safe, painless, and non-invasive alternative to a traditional liver biopsy.
How is the Liver Elastography Machine market segmented by type?
By type, the market is segmented into Trolley-mounted and Portable.
What are the key applications of Liver Elastography Machine?
Key applications covered include Hospitals & Clinics and Physical Examination Centers.
Which companies are profiled in the Liver Elastography Machine market report?
Key players profiled include Echosens (Furui Medical), GE HealthCare, Royal Philips, Siemens Healthineers AG, Canon Medical, FUJIFILM Healthcare, Hologic and Wuxi Haisi Kaier Medical Technology, among 11 companies covered in total.
What geographies does the Liver Elastography Machine market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Liver Elastography Machine?
What factors are driving Liver Elastography Machine market growth, globally and by region?
Who should buy the Liver Elastography Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospitals & Clinics and Physical Examination Centers, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Liver Elastography Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from US$ 3.500,00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.